quinazolines has been researched along with Cancer of the Tongue in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, WY; Chen, YA; Chiu, SJ; Ho, CL; Hwu, L; Ku, MT; Liu, RS; Lu, CH | 1 |
| Chen, J; Sun, Y; Wang, J; Wu, Y; Zhang, Y; Zhao, J | 1 |
| Bozec, A; Cayre, A; Dental, C; Etienne-Grimaldi, MC; Fischel, JL; Formento, P; Gros, FX; Milano, G; Penault-Llorca, F | 1 |
| Hu, JA; Huang, HJ; Ping, FY; Zhao, SF | 1 |
| Furukawa, M; Inoue, H; Kakudo, K; Nozaki, M; Ohnishi, Y | 1 |
| Hamakawa, H; Li, C; Mihara, M; Nakashiro, K; Shintani, S | 1 |
| Jeon, NK; Kim, J; Lee, EJ; Whang, JH | 1 |
7 other study(ies) available for quinazolines and Cancer of the Tongue
| Article | Year |
|---|---|
Detection of cancer stem cells by EMT-specific biomarker-based peptide ligands.
Topics: Animals; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Dimethyl Sulfoxide; Epithelial-Mesenchymal Transition; Humans; Ligands; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Peptides; Quinazolines; Spheroids, Cellular; Tongue Neoplasms; Tumor Burden; Vimentin; Xenograft Model Antitumor Assays | 2021 |
Gene regulation analysis of the effects of evodiamine on tongue squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Oligonucleotide Array Sequence Analysis; Quinazolines; Tongue Neoplasms | 2019 |
Vertical VEGF targeting: A combination of ligand blockade with receptor tyrosine kinase inhibition.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Apoptosis; Bevacizumab; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Drug Combinations; Female; Humans; Immunohistochemistry; Mice; Mice, Nude; Neovascularization, Pathologic; Quinazolines; Tongue Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2008 |
Downregulation of Notch1 and its potential correlation with epidermal growth factor receptor signalling in tongue squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Down-Regulation; Enzyme Inhibitors; Epithelial Cells; ErbB Receptors; Gene Silencing; Humans; Inverted Repeat Sequences; Metaplasia; Mouth Mucosa; Plasmids; Quinazolines; Receptor, Notch1; RNA; Signal Transduction; Tongue; Tongue Neoplasms; Transfection; Tyrphostins; Up-Regulation | 2010 |
Heparin-binding epidermal growth factor-like growth factor is a potent regulator of invasion activity in oral squamous cell carcinoma.
Topics: ADAM Proteins; ADAM17 Protein; Autocrine Communication; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; ErbB Receptors; Heparin-binding EGF-like Growth Factor; Humans; Hydroxamic Acids; Intercellular Signaling Peptides and Proteins; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Protease Inhibitors; Protein Kinase Inhibitors; Quinazolines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; Signal Transduction; Time Factors; Tongue Neoplasms; Tyrphostins | 2012 |
Gefitinib ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, mediates the inhibition of lymph node metastasis in oral cancer cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Enzyme Inhibitors; ErbB Receptors; Fibronectins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Focal Adhesions; Gefitinib; Green Fluorescent Proteins; Integrins; Luminescent Proteins; Lymph Nodes; Lymphatic Metastasis; Mice; Phosphorylation; Protein-Tyrosine Kinases; Quinazolines; Tongue Neoplasms; Tumor Cells, Cultured | 2003 |
The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses proliferation and invasion of human oral squamous carcinoma cells via p53 independent and MMP, uPAR dependent mechanism.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Gefitinib; Humans; Matrix Metalloproteinases; Neoplasm Invasiveness; Protein Kinase Inhibitors; Quinazolines; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Tongue Neoplasms; Tumor Suppressor Protein p53 | 2007 |